diagnosis_age,metastasis_stage_code,neoplasm_lymph_code,neoplasm_disease_stage_code,tumor_stage_code,cancer_type_detailed,disease_free_months,disease_free_status,er_status_ihc,er_status_ihc_percent_positive,ethnicity_category,fraction_genome_altered,her_2_fish_status,her_2_ihc_percent_positive,her_2_ihc_score,neoplasm_histologic_type,neoadjuvant_therapy,ihc_her_2,year_initial_diagnosis,lymph_presentation,positive_lymph_hematoxylin,lymph_examined_number,menopause_status,metastatic_tumor_indicator,biospecimen_method,micromet_detection_ihc,mutation_count,oct_embedded,oncotree_code,overall_survival_months,overall_survival_status,disease_surgical_margin_status,primary_tumor_site,tissue_prospective_indicator,pr_status_ihc,race_category,sex,staging_system,surgical_procedure_first,tmb_nonsynonymous,person_neoplasm_status,Cluster
90.0,m0,nx,stage iia,t2,breast invasive ductal carcinoma,38.6,diseasefree,positive,10-19%,not hispanic or latino,0.2724,positive,<10%,1.0,infiltrating ductal carcinoma,no,positive,2009.0,no,4.8,10.5,post,no,core needle biopsy,no,3860.0,False,idc,5.7,deceased,negative,C50.911,retrospective,negative,white,female,axillary lymph node dissection alone,simple mastectomy,128.4,tumor free,Cluster 2
